Releasing the data, the International Air Transport Association...
Category:
Non-Life
Latest
Fast-growing Asian economies China, India,Thailand and Philippines most vulnerable to climate change: Swiss Re Report
Risk reduction through adaptation fosters insurability. The...
Red Sea attacks add urgency to Mideast Trade route
Almost all of India’s trade with Europe goes through the Red Sea...
New Delhi ambulance group grapples with surging COVID-19 quarantine deaths
Currently more than 23,000 people are recovering at home in Delhi, which has been recording a total of around 100 deaths a day this month and more than 5,000 infections.
“Corona has gone out of control in Delhi,” said Shunty, who founded the non-governmental organisation more than 25 years ago. It runs 16 ambulances, almost all of them working overtime these days.
“Too many deaths are happening, especially among the old and people with other complications.”
UK asks regulator to assess AZ-Oxford vaccine amid questions
The step comes amid questions about preliminary results from trials of the jab, after the company and the university acknowledged that the most encouraging part of their findings stemmed from a dosing error.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency (MHRA) to determine whether the vaccine “meets rigorous safety standards.”
Covid-19 virus may hijack our cells’ cholesterol system to spread through body:says study
They say this hints at new targets for treatment, although this is very early-stage research.
The study suggests that SARS-CoV-2 may use the cell’s internal cholesterol mechanisms to enhance infection.
International passenger flights to remain suspended till December 31
However, these restrictions won’t apply to cargo operations and services approved by the DGCA.
The DGCA also added that select international flights on limited routes may be allowed by competent authorities on case to case basis.
Action needed to spur British government-backed pandemic insurance, says project chair
Stephen Catlin, chairman of the Pandemic Re Steering Committee, a British industry group, said he had hoped in early June that a launch would be possible in 2021.“But as time went on, it became clear that the complexity was going to slow it down,” Catlin, who is also chairman and CEO of insurer Convex, told the Reuters Events Future of Insurance Europe conference.
Govt launches ‘Mission Covid Suraksha’ to help accelerate vaccine candidates
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said.
Earlier this month, the government had announced a package of Rs 900 crore for vaccines.
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Besides, Covaxin, four other vaccines are under different phases of clinical trial in India with the Serum Institute of India conducting phase-three trial of the Oxford-Astrazeneca Covid-19 vaccine while the indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country.
Over 50,000 Ayushman Bharat Health and Wellness Centres operational across country
AstraZeneca faces more Covid-19 vaccine questions after manufacturing error
In a statement, Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one. When it was apparent that a lower dose was used, it was discussed with regulators, and an agreement was reached to push ahead with the two regimens, the statement said.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”